9th SA AIDS Conference 2019

SA AIDS Conference 2019

Unprecedented innovations and technologies: HIV and change

The 9th South African AIDS Conference, taking place on 11-14 June 2019, will focus on unprecedented scientific, social and digital innovations/technologies which could expand possibilities and opportunities towards controlling the HIV & AIDS epidemic.

The conference will determine how contemporary explosive and disruptive technologies will contribute towards sustained HIV prevention efforts, HIV testing, ART uptake and adherence, trigger the development of new drugs, effectively utilise enormous volumes of data and improve communication and service delivery and eventually end the epidemic.  

Milestones, initiatives, strategies, models, systems and best practices in accelerating the control of the epidemic ahead of the 2020 global targets will be highlighted through the following five conference tracks:

  • Track 1: Clinical science and bio-medical innovations, technologies and responses 
  • Track 2: Possibilities and limits of big data - Epidemiology, mathematical modelling & surveillance
  • Track 3: Implementation science: Technologies, innovations and methods for scaling up effective interventions
  • Track 4: Social drivers of the epidemic: Society, race, class, culture, stigma, violence, diversity and challenges
  • Track 5: Social justice: Relationships and power – community, policies, laws, health systems, human rights, donor agencies and the state

Look out for our regular updates, related content, and live coverage from the conference on this page, as well as on Twitter and Facebook, and visit us at exhibition booth #40 if you’re also attending the conference!

Download the conference programme here. [29MB]

May 28, 2019
Year of publication
Resource types
9th South African AIDS Conference, HIV prevention, HIV testing and counseling (HTC), antiretroviral therapy (ART), HIV self-testing (HIVST), SA AIDS 2019
ECHO presentation

A Roadmap for Results - Understanding the ECHO Trial Findings

Results from the Evidence for Contraceptive Options and HIV Outcomes (ECHO) Study were released at a session at the 9th South African AIDS Conference (SA AIDS 2019) in Durban, South Africa, on Thursday, June 13th. The session, which included presentations on the primary analysis, was recorded and can be viewed on YouTube here.
ECHO study Fact Sheet

ECHO Study Factsheet

The Evidence for Contraceptive Options and HIV Outcomes (ECHO) Study is an open-label randomised clinical trial comparing three highly effective, reversible methods of contraception — a progestogen-only injectable called depot-medroxyprogesterone acetate (DMPA), a levonorgestrel implant and the non-hormonal copper intrauterine device — to evaluate whether there is any difference in the risk of acquiring HIV infection among users of these methods.Read this fact sheet for more about the ECHO study.
SA AIDS 2019 blog

SHARE-ing social media strategies for success: What’s worked for us

The Southern Africa HIV and AIDS Regional Exchange (SHARE) was first developed in 2011 to address the need for a free, user-friendly space for online knowledge sharing of locally-relevant HIV and AIDS information. Since its inception, SHARE has connected thousands of people to resources, peers, organizations, online learning, and tools for collaboration. Almost daily, SHARE posts new content to its social media profiles on Facebook and Twitter to further amplify what the platform has to offer. SHARE’s experiences have led to a new wealth of knowledge on what it takes to lead a successful social media strategy. Presented here are a few tips based on what has worked for us.
Anele Yawa, TAC

Participants’ expectations for the South African AIDS Conference

The SHARE team chatted with a range of delegates to find out their expectations for this week’s conference, including academics, clinicians, and representatives from civil society organizations.

Similar Resources

In our third issue, we have assembled 72 abstracts published from April through May 2018 that feature articles from Botswana (4), Lesotho (2), Malawi (7), Mozambique (5), South Africa (43), Swaziland (2), Tanzania (4), Zambia (2) and Zimbabwe (9).
In our fourth issue, we have assembled 68 abstracts published from June through July 2018 that feature evidence from Angola (1), Botswana (1), Eswatini (2), Malawi (11), Mozambique (3), South Africa (36), Zambia (6) and Zimbabwe (10).
In our fifth issue, we have assembled 70 abstracts published from August through September 2018 that feature evidence from Botswana (3), Eswatini (5), Lesotho (2), Malawi (8), Mozambique (3), Namibia (3), South Africa (40), Tanzania (1), Zambia (12) and Zimbabwe (9).
In our sixth issue, we have assembled 105 abstracts published from October through December 2018 that feature evidence from Botswana (4), Eswatini (5), Lesotho (2), Malawi (8), Mozambique (6), Namibia (2), South Africa (62), Tanzania (1), Zambia (12) and Zimbabwe (10).
In this, our 7th, issue, we have assembled 67 abstracts published from January through February 2019 that feature evidence from Botswana (3), Eswatini (2), Lesotho (2), Malawi (16), Mozambique (3), South Africa (40), Tanzania (2), Zambia (3) and Zimbabwe (7).
In our 8th issue of our Research Digest, we have assembled 64 abstracts published from March through April 2019 that feature evidence from Botswana (2), Eswatini (2), Lesotho (2), Malawi (12), Mozambique (4), Namibia (1), South Africa (32), Tanzania (3), Zambia (11) and Zimbabwe (14).

The International AIDS Conference (IAC) is by far the largest conference on HIV related issues. This prestigious conference is the premier gathering for those working in the field of HIV, as well as policy makers, people living with HIV and others committed to ending the epidemic.

Timely access to antiretroviral treatment (ART) is vital to ensuring safe motherhood and reducing vertical transmission. Treatment guidance and programming has changed dramatically in recent years.

To understand the uptake of HIV services by adolescent women, the authors conducted a retrospective analysis of patient-level data (2011–2013) on services for antenatal care (ANC) and prevention of mother-to-child transmission (PMTCT) in 36 facilities in 5 districts in Zimbabwe.

The latest global results highlight PEPFAR-supported activities across the countries in which the organization works.